Dear Editor, Over the last 14 years, distress has been considered the sixth vital sign in oncology care. It has also been used to identify patients in need of psychosocial support and improve quality of life [1] . Since the initial publication of the National Comprehensive Cancer Network (NCCN) distress guidelines in 1999, multiple studies have been published related to the extent of distress in multiple cancer types and settings [2] . However, it is curious to note that few studies have addressed this topic in patients diagnosed with RCC [3] . The present study sought to ascertain the prevalence of distress amongst a cohort of patients diagnosed with RCC from an international survey. We also explore the relationship between levels of distress and clinicopathological characteristics.
A cross-sectional study was performed. Patients diagnosed with RCC who participated in a USA-based non-profit patient advocacy forum were invited to participate in an online survey from 1 April to 15 June 2017. We excluded responses from caregivers, practitioners and patients with non-RCC diagnoses. Through social media ('Facebook' and 'Smart Patients'), they were asked to provide clinical characteristics (demographics, histological subtype, disease stage, presence or absence of recurrence and treatment). In addition to survey questions related to other elements of their treatment, patients were assessed for distress using the Distress Thermometer (DT) proposed by the NCCN [2] . The DT is a well-known and validated measure used to identify distress level with an 11-point scale, ranging from 0 (no distress) to 10 (extreme distress). A threshold score of 4 indicates a moderate-to-severe level of distress. Descriptive statistics were generated; estimating proportions and CIs and evaluating mean values and standard deviations. Exploratory logistic regression was used to describe associations between distress and demographic and clinical characteristics.
Amongst 800 responses, 350 were excluded due to incomplete data or responses from participants without RCC. A total of 450 patients participated in this survey, with a mean (range) age of 56 (17-82) years. Most patients were White (93%), female (56%), and the most common histological subtype of RCC was clear cell (76%). The majority of patients initially had non-metastatic disease (74%), and 61% had disease recurrence (either de novo or following initially nonmetastatic disease).
A greater proportion of patients reported moderate-to-severe distress (77%), with a mean score of 6.3 (95% CI 6.0-6.6). Distress was significantly associated with female gender (regression coefficient B = 0.42, SE = 0.25; P = 0.03), younger age (B = À0.52, SE = 0.25; P = 0.03), non-clear cell histology (B = 0.47, SE = 0.34; P = 0.01), and presence of recurrence (B = 0.24, SE = 0.19; P = 0.04). Race, metastatic disease and nephrectomy were not associated with greater distress (Fig. 1 ).
In this prospective study, a high proportion of patients diagnosed with RCC reported moderate-to-severe distress through a survey proposed by an advocacy programme. Notably, this prevalence appears higher than distress reported for other cancer types [4] . This may be driven by specific subsets of patients. For instance, patients with recurrence demonstrated high levels of distress, and understandably so, as these populations face a poorer prognosis. Patients with non-clear cell histology also had higher levels of distress. This could be due to feelings of isolation and/or lack of information related to understanding of their diagnosis and treatments related to their histological subtype. Younger age and female gender were also associated with higher levels of distress, although this is a common finding across multiple studies in other cancer types [5] [6] [7] .
Limitations of the present study include a lack of data related to other potential factors (e.g., comorbid conditions, socioeconomic status) that potentially affect distress level. In addition, the present study was based on a self-reported measure, which could produce variable results depending on patient comprehension. Furthermore, the platform used to recruit patients could have impacted on our findings, limiting the generalisability of our results; e.g., the discrepancy noted between the literature and our prevalence of younger patients. Finally, it should be noted that the DT assessment is no replacement for an assessment of psychiatric morbidity by a medical professional [8] . Despite these limitations, our present study highlights a high prevalence of distress amongst patients with RCC. The present study calls for better awareness of distress in patients with RCC, specifically for younger patients and females patients. Algorithms should be developed to direct patients with high distress levels to adequate psychosocial treatment. 
